Kang N - Search Results

1

Endothelial-Specific Molecule 1 Inhibition Lessens Productive Angiogenesis and Tumor Metastasis to Overcome Bevacizumab Resistance.

Kang N, Liang X, Fan B, Zhao C, Shen B, Ji X, Liu Y. Kang N, et al. Cancers (Basel). 2022 Nov 18;14(22):5681. doi: 10.3390/cancers14225681. Cancers (Basel). 2022. PMID: 36428773 Free PMC article.

2

Optimized Expression and Characterization of a Novel Fully Human Bispecific Single-Chain Diabody Targeting Vascular Endothelial Growth Factor165 and Programmed Death-1 in Pichia pastoris and Evaluation of Antitumor Activity In Vivo.

Xiong C, Mao Y, Wu T, Kang N, Zhao M, Di R, Li X, Ji X, Liu Y. Xiong C, et al. Among authors: kang n. Int J Mol Sci. 2018 Sep 25;19(10):2900. doi: 10.3390/ijms19102900. Int J Mol Sci. 2018. PMID: 30257416 Free PMC article.

3

Biological characterisation and application of human MTH1 and monoclonal antibody preparation.

Chen C, Li X, Gu M, Di R, Kang N, Wang L, Lai Y, Liu Y, Ji X. Chen C, et al. Among authors: kang n. Oncol Rep. 2019 Mar;41(3):1851-1862. doi: 10.3892/or.2018.6942. Epub 2018 Dec 19. Oncol Rep. 2019. PMID: 30569141

4

A Novel Specific Anti-CD73 Antibody Inhibits Triple-Negative Breast Cancer Cell Motility by Regulating Autophagy.

Qiao Z, Li X, Kang N, Yang Y, Chen C, Wu T, Zhao M, Liu Y, Ji X. Qiao Z, et al. Among authors: kang n. Int J Mol Sci. 2019 Feb 28;20(5):1057. doi: 10.3390/ijms20051057. Int J Mol Sci. 2019. PMID: 30823477 Free PMC article.

5

Preparation of RGD4C fused anti-TNFα nanobody and inhibitory activity on triple-negative breast cancer in vivo.

Ji X, Han T, Kang N, Huang S, Liu Y. Ji X, et al. Among authors: kang n. Life Sci. 2020 Nov 1;260:118274. doi: 10.1016/j.lfs.2020.118274. Epub 2020 Aug 19. Life Sci. 2020. PMID: 32827545

6

Tumor necrosis factor α inhibition overcomes immunosuppressive M2b macrophage-induced bevacizumab resistance in triple-negative breast cancer.

Liu Y, Ji X, Kang N, Zhou J, Liang X, Li J, Han T, Zhao C, Yang T. Liu Y, et al. Among authors: kang n. Cell Death Dis. 2020 Nov 19;11(11):993. doi: 10.1038/s41419-020-03161-x. Cell Death Dis. 2020. PMID: 33214550 Free PMC article.

7

Novel specific anti-ESM1 antibodies overcome tumor bevacizumab resistance by suppressing angiogenesis and metastasis.

Kang N, Fan B, Sun Y, Xue P, Liu Y. Kang N, et al. Cancer Sci. 2023 Nov;114(11):4413-4425. doi: 10.1111/cas.15939. Epub 2023 Sep 16. Cancer Sci. 2023. PMID: 37715566 Free PMC article.

8

Targeting MutT Homolog 1 (MTH1) for Breast Cancer Suppression by Using a Novel MTH1 Inhibitor MA-24 with Tumor-Selective Toxicity.

Kang N, Ma J, Hu Y, Di R, Wang L, Zhang X, Lai Y, Liu Y. Kang N, et al. Pharmaceuticals (Basel). 2024 Feb 23;17(3):291. doi: 10.3390/ph17030291. Pharmaceuticals (Basel). 2024. PMID: 38543077 Free PMC article.

9

A new perspective on antiangiogenic antibody drug resistance: Biomarkers, mechanisms, and strategies in malignancies.

Zhao C, Zeng Y, Kang N, Liu Y. Zhao C, et al. Among authors: kang n. Drug Dev Res. 2024 Sep;85(6):e22257. doi: 10.1002/ddr.22257. Drug Dev Res. 2024. PMID: 39245913 Review.

10

Efficient generation of gene-modified pigs via injection of zygote with Cas9/sgRNA.

Wang Y, Du Y, Shen B, Zhou X, Li J, Liu Y, Wang J, Zhou J, Hu B, Kang N, Gao J, Yu L, Huang X, Wei H. Wang Y, et al. Among authors: kang n. Sci Rep. 2015 Feb 5;5:8256. doi: 10.1038/srep08256. Sci Rep. 2015. PMID: 25653176 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,081 results

Search Page

Filters